Found 182 results
[ Author(Desc)] Keyword Title Type Year
Filters: First Letter Of Keyword is O  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
Iwaniec UT, Turner RT, Smith BJ, Stoecker BJ, Rust A, Zhang B, Vasu VT, Gohil K, Cross CE, Traber MG.  2013.  Evaluation of long-term vitamin E insufficiency or excess on bone mass, density, and microarchitecture in rodents.. Free Radic Biol Med. 65:1209-1214.
J
Johnson LA, Zuloaga KL, Kugelman TL, Mader KS, Morré JT, Zuloaga DG, Weber S, Marzulla T, Mulford A, Button D et al..  2016.  Amelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma.. EBioMedicine. 3:26-42.
Joshi AD, Carter DE, Harper TA, Elferink CJ.  2015.  Aryl hydrocarbon receptor-dependent stanniocalcin 2 induction by cinnabarinic acid provides cytoprotection against endoplasmic reticulum and oxidative stress.. J Pharmacol Exp Ther. 353(1):201-12.
Joshi AD, Carter DE, Harper TA, Elferink CJ.  2015.  Aryl hydrocarbon receptor-dependent stanniocalcin 2 induction by cinnabarinic acid provides cytoprotection against endoplasmic reticulum and oxidative stress.. J Pharmacol Exp Ther. 353(1):201-12.
Jump DB, Torres-Gonzalez M, L Olson K.  2011.  Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation.. Biochem Pharmacol. 81(5):649-60.
Jump DB, Depner CM, Tripathy S, Lytle KA.  2015.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.. Adv Nutr. 6(6):694-702.
Jump DB, Depner CM, Tripathy S, Lytle KA.  2015.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.. Adv Nutr. 6(6):694-702.
Jump DB, Tripathy S, Depner CM.  2013.  Fatty acid-regulated transcription factors in the liver.. Annu Rev Nutr. 33:249-69.
Jurka J, Pethiyagoda C.  1995.  Simple repetitive DNA sequences from primates: compilation and analysis.. J Mol Evol. 40(2):120-6.
K
Kacsóh B, Tóth BE, Avery LM, Grosvenor CE.  1993.  In vitro control of prolactin (PRL) and growth hormone secretion of neonatal rat pituitary glands: effects of ovine PRL, salmon calcitonin, endothelin-3, angiotensin II, bromocryptine and somatostatin.. Life Sci. 52(3):259-69.
Katchamart S, Williams DE.  2001.  Indole-3-carbinol modulation of hepatic monooxygenases CYP1A1, CYP1A2 and FMO1 in guinea pig, mouse and rabbit.. Comp Biochem Physiol C Toxicol Pharmacol. 129(4):377-84.
Kirkwood JS, Legette LCL, Miranda CL, Jiang Y, Stevens JF.  2013.  A metabolomics-driven elucidation of the anti-obesity mechanisms of xanthohumol.. J Biol Chem. 288(26):19000-13.
Kirkwood JS, Miranda CL, Bobe G, Maier CS, Stevens JF.  2016.  18O-Tracer Metabolomics Reveals Protein Turnover and CDP-Choline Cycle Activity in Differentiating 3T3-L1 Pre-Adipocytes.. PLoS One. 11(6):e0157118.
Krueger SK, Henderson MC, Siddens LK, VanDyke JE, Benninghoff AD, P Karplus A, Furnes B, Schlenk D, Williams DE.  2009.  Characterization of sulfoxygenation and structural implications of human flavin-containing monooxygenase isoform 2 (FMO2.1) variants S195L and N413K.. Drug Metab Dispos. 37(8):1785-91.
Krueger SK, Williams DE, Yueh M-F, Martin SR, Hines RN, Raucy JL, Dolphin CT, Shephard EA, Phillips IR.  2002.  Genetic polymorphisms of flavin-containing monooxygenase (FMO).. Drug Metab Rev. 34(3):523-32.
Krueger SK, Martin SR, Yueh M-F, Pereira CB, Williams DE.  2002.  Identification of active flavin-containing monooxygenase isoform 2 in human lung and characterization of expressed protein.. Drug Metab Dispos. 30(1):34-41.
Krueger SK, Henderson MC, Siddens LK, VanDyke JE, Benninghoff AD, P Karplus A, Furnes B, Schlenk D, Williams DE.  2009.  Characterization of sulfoxygenation and structural implications of human flavin-containing monooxygenase isoform 2 (FMO2.1) variants S195L and N413K.. Drug Metab Dispos. 37(8):1785-91.
Kubglomsong S, Theerakulkait C, Reed RL, Yang L, Maier CS, Stevens JF.  2018.  Isolation and Identification of Tyrosinase-Inhibitory and Copper-Chelating Peptides from Hydrolyzed Rice-Bran-Derived Albumin.. J Agric Food Chem. 66(31):8346-8354.
Kuiper HC, Stevens JF.  2011.  LC-MS/MS quantitation of mercapturic acid conjugates of lipid peroxidation products as markers of oxidative stress.. Curr Protoc Toxicol. Chapter 17:Unit17.14.2.
Kuiper HC, Bruno RS, Traber MG, Stevens JF.  2011.  Vitamin C supplementation lowers urinary levels of 4-hydroperoxy-2-nonenal metabolites in humans.. Free Radic Biol Med. 50(7):848-53.
Kuiper HC, Bruno RS, Traber MG, Stevens JF.  2011.  Vitamin C supplementation lowers urinary levels of 4-hydroperoxy-2-nonenal metabolites in humans.. Free Radic Biol Med. 50(7):848-53.
Kuiper HC, Langsdorf BL, Miranda CL, Joss J, Jubert C, Mata JE, Stevens JF.  2010.  Quantitation of mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites in a smoking cessation study.. Free Radic Biol Med. 48(1):65-72.
Kuiper HC, Miranda CL, Sowell JD, Stevens JF.  2008.  Mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites are in vivo markers of oxidative stress.. J Biol Chem. 283(25):17131-8.
Kuschner CE, Choi J, Yin T, Shinozaki K, Becker LB, Lampe JW, Kim J.  2018.  Comparing phospholipid profiles of mitochondria and whole tissue: Higher PUFA content in mitochondria is driven by increased phosphatidylcholine unsaturation.. J Chromatogr B Analyt Technol Biomed Life Sci. 1093-1094:147-157.
L
Larsen-Su SA, Krueger SK, Yueh MFei, Pereira CB, Williams DE.  2002.  Developmental regulation of flavin-containing monooxygenase form 1 in the liver and kidney of fetal and neonatal rabbits.. Biochem Pharmacol. 63(7):1353-9.

Pages